Cargando…

Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy

INTRODUCTION: Gaucher disease is the first lysosomal disease to benefit from enzyme replacement therapy, thus serving as model for numerous other lysosomal diseases. Alglucerase was the first glucocerebrosidase purified from placental extracts, and this was then replaced by imiglucerase – a Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Serratrice, Christine, Carballo, Sebastian, Serratrice, Jacques, Stirnemann, Jérome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072572/
https://www.ncbi.nlm.nih.gov/pubmed/27790078
http://dx.doi.org/10.2147/CE.S93717